Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factors affecting time to maintenance dose in patients initiating warfarin.

Pharmacoepidemiology and drug safety - 1 Mar 2015

Finkelman Brian S, French Benjamin, Bershaw Luanne, Kimmel Stephen E

Abstract excerpt

PURPOSE: Patients starting warfarin often experience lengthy dose-titration periods, when they are at high risk for bleeding and thromboembolism. However, relatively little is known about why some patients take longer than others to reach maintenance dose. Thus, we sought to identify social, clinical, and genetic factors associated with prolonged time to maintenance dose (TTM). METHODS: We conducted a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Anticoagulants
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Maintenance Chemotherapy

Share to Patient Acceptance of Health Care

Share to Time Factors

Share to Warfarin

Source

Open in PubMed Open full text

Identifiers

PMID: 25504915
DOI: 10.1002/pds.3735
PMCID: PMC4570031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factors affecting time to maintenance dose in patients initiating warfarin.PMID 25504915Read ↗

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.Semantic proximity Read ↗

Time-to-event modeling for achieving a stable warfarin dose using genetic and non-genetic covariates.Semantic proximity Read ↗

Anticoagulation trends in adults aged 65 and over with atrial fibrillation; a cohort studySemantic proximity Read ↗

Adherence and variability in warfarin dose requirements: assessment in a prospective cohort.Semantic proximity Read ↗

Predictors of Anticoagulant Treatment Control in New Warfarin Patients in JordanSemantic proximity Read ↗

Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients.Semantic proximity Read ↗

Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?Semantic proximity Read ↗

Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy.Semantic proximity Read ↗

Adjustment for ‘Prescriber Type’ in Pharmacoepidemiological AnalysesSemantic proximity Read ↗

Factors associated with initiation of bone-health medication among older adults in primary care in IrelandSemantic proximity Read ↗

Exploring provider perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapySemantic proximity Read ↗

Simultaneous use of amiodarone influences warfarin maintenance dose but is not associated with adverse events.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.